Shipping of generic Flonase resumes

March 13, 2006

A Maryland U.S. District Court has denied GlaxoSmithKline's motion for a preliminary injunction to set aside the FDA's decision to approve fluticasone propionate nasal spray, the generic version of Flonase. The court also lifted the suspension of the FDA's approval of a generic version of the spray, and the temporary restraining order previously granted to Glaxo was allowed to expire.

Shipping of generic Flonase resumes

A Maryland U.S. District Court has denied GlaxoSmithKline's motion for a preliminary injunction to set aside the FDA's decision to approve fluticasone propionate nasal spray, the generic version of Flonase. The court also lifted the suspension of the FDA's approval of a generic version of the spray, and the temporary restraining order previously granted to Glaxo was allowed to expire. Following these decisions, Roxane Laboratories resumed shipping their AB-rated generic version of the spray to wholesalers and pharmacies. Glaxo also began shipping its own generic Flonase through its authorized generic distributor Par Pharmaceuticals

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.